Literature DB >> 21309738

Anti-inflammatory effects of anti-hypertensive agents: influence on interleukin-1β secretion by peripheral blood polymorphonuclear leukocytes from patients with essential hypertension.

Farkhondeh Nemati1, Nahid Rahbar-Roshandel, Fatemeh Hosseini, Massoud Mahmoudian, Massoumeh Shafiei.   

Abstract

The effects of clinically relevant concentrations of anti-hypertensive agents on lipopolysaccharide (LPS)-induced interleukin-1beta (IL-1β) secretion by polymorphonuclear leukocytes (PMNs) were investigated in vitro. Lipopolysaccharide-induced secretion of IL-1β by PMNs from 15 hypertensive and 15 normotensive subjects after incubation with losartan, captopril, amlodipine, atenolol, and hydrochlorothiazide were assessed. IL-1β secretion by PMNs markedly increased in hypertensive patients versus normotensive subjects. Losartan, captopril, and amlodipine caused a concentration-dependent attenuation of IL-1β levels in both groups. Losartan, captopril, and amlodipine demonstrated marked in vitro anti-inflammatory effects at clinically relevant serum concentrations but atenolol and hydrochlorothiazide did not.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21309738     DOI: 10.3109/10641963.2010.496521

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  14 in total

1.  Low-dose atorvastatin, losartan, and particularly their combination, provide cardiovascular protection in isolated rat heart and aorta.

Authors:  Mojca Lunder; Lovro Ziberna; Miodrag Janić; Aleš Jerin; Milan Skitek; Mišo Sabovič; Gorazd Drevenšek
Journal:  Heart Vessels       Date:  2012-05-21       Impact factor: 2.037

Review 2.  Dendritic Cell Epithelial Sodium Channel in Inflammation, Salt-Sensitive Hypertension, and Kidney Damage.

Authors:  Lale A Ertuglu; Annet Kirabo
Journal:  Kidney360       Date:  2022-06-27

3.  Osteopontin circulating levels correlate with renal involvement in systemic lupus erythematosus and are lower in ACE inhibitor-treated patients.

Authors:  Marco Quaglia; Annalisa Chiocchetti; Tiziana Cena; Claudio Musetti; Sara Monti; Nausicaa Clemente; Umberto Dianzani; Corrado Magnani; Piero Stratta
Journal:  Clin Rheumatol       Date:  2014-05-13       Impact factor: 2.980

4.  Angiotensin converting enzyme-inhibitor reduces colitis severity in an IL-10 knockout model.

Authors:  Ryo Sueyoshi; Kathleen M Woods Ignatoski; Stephanie Daignault; Manabu Okawada; Daniel H Teitelbaum
Journal:  Dig Dis Sci       Date:  2013-08-15       Impact factor: 3.199

5.  MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216.

Authors:  Joannes A A Reijers; D G Kallend; K E Malone; J W Jukema; P L J Wijngaard; J Burggraaf; M Moerland
Journal:  Cardiovasc Drugs Ther       Date:  2017-08       Impact factor: 3.727

Review 6.  Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?

Authors:  Daniela Maria Tanase; Evelina Maria Gosav; Smaranda Radu; Anca Ouatu; Ciprian Rezus; Manuela Ciocoiu; Claudia Florida Costea; Mariana Floria
Journal:  Int J Hypertens       Date:  2019-05-02       Impact factor: 2.420

7.  The Crucial Role of Plaque Control in Peri-Implant Mucositis Initiation as Opposed to the Role of Systemic Health Condition: A Cross-Sectional Study.

Authors:  Ali Raad AbdulAzeez; Athil Adnan Alkinani
Journal:  Clin Cosmet Investig Dent       Date:  2021-06-25

8.  Inflammatory cytokines and plasma redox status responses in hypertensive subjects after heat exposure.

Authors:  S F Fonseca; V A Mendonça; M C Teles; V G C Ribeiro; R Tossige-Gomes; C D C Neves; E Rocha-Vieira; L H R Leite; D D Soares; C C Coimbra; A C R Lacerda
Journal:  Braz J Med Biol Res       Date:  2016-02-02       Impact factor: 2.590

9.  T-lymphocyte Kv1.3 channel activation triggers the NLRP3 inflammasome signaling pathway in hypertensive patients.

Authors:  Jian Zhu; Yan Yang; Si-Gan Hu; Qiu-Bing Zhang; Jie Yu; Yuan-Ming Zhang
Journal:  Exp Ther Med       Date:  2017-05-22       Impact factor: 2.447

10.  Losartan, but not Enalapril and Valsartan, Inhibits the Expression of IFN-γ, IL-6, IL-17F and IL-22 in PBMCs from Rheumatoid Arthritis Patients.

Authors:  Pablo R G Cardoso; Katherine A Matias; Andrea T Dantas; Claudia D L Marques; Michelly C Pereira; Angela L B P Duarte; Moacyr Jesus Barreto de Melo Rego; Ivan da Rocha Pitta; Maira Galdino da Rocha Pitta
Journal:  Open Rheumatol J       Date:  2018-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.